| Mechanical Properties of the Internal Limiting Membrane and Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy (NCT01485575) | University Hospital, Basel, Switzerland | 2011-11-01 |
| Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema (NCT01476449) | Retina Vitreous Associates of Florida | 2011-11-01 |
| Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy (NCT01478516) | Hallym University Medical Center | 2011-11-01 |
| Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab (NCT01471691) | Hanscom, Thomas, M.D. | 2011-11-01 |
| Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome (NCT01945892) | Ludwig-Maximilians - University of Munich | 2011-11-01 |
| Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion (NCT01427751) | Allergan | 2011-10-11 |
| Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections. (NCT01449682) | Retina Macula Institute | 2011-10-01 |
| A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO) (NCT01445626) | Allergan | 2011-10-01 |
| Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion (NCT01428388) | Barnes Retina Institute | 2011-09-01 |
| Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) (NCT01396083) | Novartis Pharmaceuticals | 2011-08-01 |
| Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane (NCT01410201) | Barnes Retina Institute | 2011-08-01 |
| DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO) (NCT01662518) | Centro de Pesquisa Rubens Siqueira | 2011-07-01 |
| Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) (NCT01396057) | Novartis Pharmaceuticals | 2011-07-01 |
| Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO) (NCT01411696) | Allergan | 2011-07-01 |
| A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema (NCT01315275) | Novartis Pharmaceuticals | 2011-02-01 |
| A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion (NCT01277302) | Genentech, Inc. | 2011-02-01 |
| Use of Diagnostic Dye to Identify Areas of Leakeage,in the Retina, Prior to Receiving Focal Laser Treatment (NCT01792141) | Retina Institute of Hawaii | 2011-01-01 |
| REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study (NCT01247220) | Retina Associates of Florida, P.A. | 2010-11-01 |
| Autofluorescence in Uveitic and Diabetic Macular Edema (NCT00956124) | St. Franziskus Hospital | 2010-10-01 |
| Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema (NCT01298076) | University of Sydney | 2010-10-01 |
| Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) (NCT01231633) | Long Island Vitreoretinal Consultants | 2010-09-01 |
| Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) (NCT01202461) | Samsung Medical Center | 2010-08-01 |
| Ozurdex for Macular Edema Post Membrane Peeling (NCT01273727) | Retina Specialists, PC | 2010-06-01 |
| Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina (NCT02088151) | Insel Gruppe AG, University Hospital Bern | 2010-06-01 |
| A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema (NCT01100307) | Pfizer | 2010-05-01 |
| Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema (NCT01487629) | University of Sao Paulo | 2010-04-01 |
| Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO) (NCT01027650) | Allergan | 2010-03-01 |
| Prophylactic Ketorolac Post Epiretinal Membrane Surgery (NCT00974753) | Queen's University | 2010-03-01 |
| Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery (NCT01395069) | Queen's University | 2010-02-01 |
| Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS) (NCT01030601) | University Health Network, Toronto | 2010-01-01 |
| Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids (NCT00846625) | University of Utah | 2009-11-01 |
| Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis (NCT00918554) | Assistance Publique - Hôpitaux de Paris | 2009-09-01 |
| Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion (NCT00969293) | Fovea Pharmaceuticals SA | 2009-09-01 |
| Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion (NCT00970957) | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | 2009-09-01 |
| To Compare Visual Field Impairment in Conventional Double Frequency Nd: YAG Panretinal Photocoagulation With PASCAL Panretinal Photocoagulation (NCT01023113) | L.V. Prasad Eye Institute | 2009-09-01 |
| Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema (NCT00994799) | Szeged University | 2009-07-01 |
| Avastin for Post-photocoagulation Macular Edema (NCT00801866) | Asociación para Evitar la Ceguera en México | 2008-12-01 |
| Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) (NCT00942864) | Novartis Korea Ltd. | 2008-12-01 |
| Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography (NCT00797524) | Association for Innovation and Biomedical Research on Light and Image | 2008-11-01 |
| A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients (NCT00782717) | Alcon Research | 2008-11-01 |
| Microperimetry in Macular Edema (NCT00791726) | St. Franziskus Hospital | 2008-11-01 |
| Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation (NCT00801905) | Asociación para Evitar la Ceguera en México | 2008-08-01 |
| Angiographie and OCT in Macula and Retinal Diseases (NCT01603823) | Medical University of Vienna | 2008-08-01 |
| An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2) (NCT01442064) | Genentech, Inc. | 2008-07-01 |
| Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation (NCT00804206) | Asociación para Evitar la Ceguera en México | 2008-07-01 |
| A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001) (NCT00692614) | Merck Sharp & Dohme LLC | 2008-06-01 |
| Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema (NCT00900887) | Hospital Juarez de Mexico | 2008-04-01 |
| Major and Macular Branched Retinal Venous Occlusion (NCT01219205) | Hallym University Medical Center | 2008-03-01 |
| Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) (NCT00562406) | Klinikum Ludwigshafen | 2007-11-01 |
| Morphological and Functional Retinal Changes Following Retinal Photocoagulation (NCT00682240) | Medical University of Vienna | 2007-10-01 |
| A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE) (NCT00485836) | Genentech, Inc. | 2007-07-01 |
| A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) (NCT00486018) | Genentech, Inc. | 2007-07-01 |
| A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE) (NCT00473382) | Genentech, Inc. | 2007-06-01 |
| A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) (NCT00473330) | Genentech, Inc. | 2007-06-01 |
| A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO (NCT00567697) | Aleris Helse | 2007-03-01 |
| Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II) (NCT00668785) | Jumper, J. Michael, M.D. | 2007-03-01 |
| Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT) (NCT00564291) | Sebastian Wolf | 2007-01-01 |
| Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD) (NCT00726973) | Lahey Clinic | 2006-12-01 |
| Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO) (NCT00642226) | Helse Stavanger HF | 2006-11-01 |
| Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion (NCT00612261) | Yonsei University | 2006-10-01 |
| Diabetic Macular Edema Severity at Diagnosis (NCT00886392) | Hospital Juarez de Mexico | 2006-06-01 |
| Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) (NCT00729846) | California Retina Consultants | 2006-05-01 |
| Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema (NCT00309192) | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | 2006-04-01 |
| Combined Triple Therapy in Diabetic Retinopathy (DRP) (NCT00806169) | Johann Wolfgang Goethe University Hospital | 2006-04-01 |
| Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis (NCT00344253) | Heidelberg University | 2006-03-01 |
| Visual Function, Center Point Thickness and Macular Volume After Photocoagulation (NCT00906659) | Hospital Juarez de Mexico | 2006-01-01 |
| Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions (NCT00407355) | Peter A Campochiaro, MD | 2006-01-01 |
| Efalizumab to Treat Uveitis (NCT00280826) | National Eye Institute (NEI) | 2006-01-01 |
| Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications (NCT00476593) | Norwegian University of Science and Technology | 2005-09-01 |
| Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage (NCT00106132) | National Eye Institute (NEI) | 2005-03-01 |
| A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion (NCT00168298) | Allergan | 2004-11-01 |
| A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion (NCT00168324) | Allergan | 2004-10-01 |
| Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser (NCT00668239) | Hospital de Clinicas de Porto Alegre | 2004-09-01 |
| 20- Versus 23- Gauge System for Pars Plana Vitrectomy (NCT00411970) | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 2004-09-01 |
| Laser and Antioxidant Treatment of Diabetic Macular Edema (NCT00055042) | National Eye Institute (NEI) | 2003-02-01 |
| Laser and Medical Treatment of Diabetic Macular Edema (NCT00027287) | National Eye Institute (NEI) | 2001-11-01 |
| Clinical Trial on Alpha Lipoic Acid in Diabetic Macular Edema (NCT01208948) | Ludwig-Maximilians - University of Munich | 2000-07-01 |
| Intravitreal Bevacizumab for Diabetic Macular Edema (NCT00703235) | Isfahan Ophthalmology Research Center | |
| A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion (NCT00308477) | Sanwa Kagaku Kenkyusho Co., Ltd. | |
| Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab (NCT00804921) | University of Sao Paulo | |